AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories
All
|
Back to Blog
Risk Based Monitoring (RBM) is a clinical trial-monitoring technique that fulfills regulatory requirements but moves away from 100% source data verification (SDV) of patient data. It employs various tools, platforms and dashboards to identify signals, which indicate potential issues with (for example) trial conduct, safety, data integrity, compliance and enrolment.
What The Market Looks Like? The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3%. Based on the component, the RBM software market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to can be attributed to the increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base. The pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Key Factors Driving Growth in RBM Software Market: 1. Cost and time efficiency of RBM solutions 2. Rising number of clinical trials 3. Increasing government funding and grants to support clinical trials 4. Increased outsourcing of clinical trial processes to CROs Geographical Growth Analysis of Risk-based Monitoring Software Market: The Asia Pacific market is expected to grow at the highest CAGR in the forecast period. This growth can be attributed to increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region. Read more: https://www.marketsandmarkets.com/Market-Reports/risk-based-monitoring-software-market-102112429.html
0 Comments
read more
Back to Blog
Bio decontamination is largely defined as the process of neutralization as well as the removal of infectious microorganisms, chemical agents and radioactive materials. This can be attained by biology or chemicals based methods as well as by physical means.
What the Biological Decontamination Market Looks Like> The bio decontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% Pharmaceuticals and Medical Devices Companies: On the basis of end user, the biodecontamination market is segmented into pharmaceutical & medical device manufacturing companies, hospitals & healthcare facilities, and life sciences & biotechnology research organizations. In 2018, the pharmaceutical & medical device manufacturing companies segment accounted for the largest market share and highest growth rate, owing to the growing adoption of biodecontamination products & services by pharmaceutical and medical device manufacturing industries to adhere to stringent regulations. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Key Factors Driving Growth in Bio Decontamination Industry: 1. Rising Incidence of Hospital-Acquired Infections 2. Increasing Number of Surgical Procedures 3. Increasing Outsourcing of Bio decontamination Services 4. Growth in the Pharmaceutical and Biotechnology Industries 5. Presence of Stringent Regulations Emerging economies are expected to provide a wide range of growth opportunities for players in the market. The study objectives are to present Bio Decontamination Market development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. Read more: https://www.marketsandmarkets.com/Market-Reports/bio-decontamination-market-104696777.html Key Players in Bio Decontamination Market: The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc. (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).
Back to Blog
Healthcare Business Intelligence (BI) Market Worth USD 8.9 Billion Reshaping The Healthcare Industry5/21/2020 Healthcare business intelligence is the process by which large scale data from the massive healthcare industry can be collected and refined into actionable insights from key healthcare areas like costs, pharmaceuticals, clinical data, and patient behaviour.
The study involved four major activities to estimate the current size of the market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. What the market looks like? The healthcare business intelligence (BI) market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3%. On the basis of component, the healthcare BI market is segmented into platforms, software, and services. In 2018, the healthcare business intelligence platforms segment are expected to account for the largest share of the market. The large share of this market segment is mainly driven by the increasing requirement for customized BI solutions catering to individual requirements of organizations and allowing them the flexibility to build and integrate BI solutions into existing healthcare business applications for higher efficiency and reduced costs. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252368925 Key Factors Driving Market Growth: 1. Adoption of Data-Driven Decision-Making 2. Implementation of Government Initiatives to Increase EHR Adoption 3. Growing Pressure to Curb Healthcare Spending and Improve Patient Outcomes 4. Big Data in Healthcare 5. Increasing Number of Patient Registries 6. Advanced Analytics Enhancing Traditional Bi 7. Growing Demand for Cloud-Based Healthcare BI Solutions Key Players in Healthcare Business Intelligence Market: The market is highly competitive in nature, with several big as well as emerging players. Prominent players in this market include Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US).
Back to Blog
Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors. The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control.
What the market looks like? The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%. Based on type, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy. The external beam radiotherapy segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the reduced risk of radiation exposure in external beam radiotherapy and the increased precision and accuracy of tumor targeting in this therapy. Download PDF Brochure: Radiotherapy Market What drives the market? The growth of the global market for Radiotherapy is primarily influenced by the following factors: 1. Technological Advancements 2. Rising Prevalence of Cancer 3. Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy 4. Growing Use of Particle Therapy for Cancer Treatment 5. Emerging Markets The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. Read more about Radiotherapy Market: https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Back to Blog
Rapid advances in technology have demonstrated the capability of terahertz spectroscopy in various healthcare applications. The focus on using terahertz spectroscopy in biomedical applications has increased rapidly, and several studies are being conducted to investigate its potential applications in pharmaceutical quality control, protein characterization, and cancer detection. T-rays are non-invasive and non-ionizing and thus can be focused harmlessly on the body to capture signs of cancer. Due to these advantages, terahertz spectroscopy is used in a number of cancer-related research activities. This is key factor increasing demand of molecular spectroscopy market.
What the Industry Looks Like? The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%. Pharmaceutical Application: Based on application, the molecular spectroscopy market is segmented into pharmaceutical applications, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application, academic research and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of molecular spectroscopy in various stages of drug development and increasing R&D in pharmaceutical industries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50034395 Key Factors Driving Industry Growth: 1. Applications of Molecular Spectroscopy in Environmental Screening 2. Growing Use of Molecular Spectroscopy in Pharmaceutical & Biotechnology Industries 3. Technological Advancements in Molecular Spectroscopy Systems 4. Growing Focus on Ensuring the Quality of Food Products 5. Potential Applications of Terahertz Spectroscopy in Healthcare Key Players in Molecular Spectroscopy Market: Bruker (US), Thermo Fisher Scientific, Inc. (U.S), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd. (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US) Bruker corporation, Inc. (U.S.) is one of the major player in the molecular spectroscopy market in 2016. The company provides a wide range of molecular spectroscopy technologies, accessories, and software in the market. |